News

MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.
Schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) are among the world’s most persistent neglected tropical diseases (NTDs) — a group of conditions that disproportionately affect the world ...
Merck KGaA has finally claimed an FDA approval for its oral MS therapy Mavenclad, eight years after being turned down by the US regulator.
Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad.
Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertiseVANCOUVER, Wash., July 07, 2025 (GLOBE NEWSWIRE) -- ...
Infants of mothers treated in the first trimester with TMP-SMX appeared to have a higher risk for any malformation than those ...
Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...
US pharmaceutical companies will be forced to answer questions this week from lawmakers, who have been grilling them on their ...
Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with ...
The primary exposure was a first-trimester prescription fill of nitrofurantoin, TMP-SMX, fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin), and β-lactams to treat UTI. Any congenital ...
The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...
Thimerosal is only used in multi-dose vials of flu shots in the US during the 2024-25 flu season, despite decades of studies showing no related safety issues.